AVNeo® Newsle)er
Are you interested in training
for the AVNeo® procedure?
Training is fundamental for the AVNeo
procedure. JOMDD is supported by a
network of ten (10) proctors worldwide
who are responsible for supporDng
cardiac surgeons through their learningjourney.
Module I begins with didacDc lectures
where surgeons learn the beneﬁts,outcomes, and ideal paDent populaDons
for the AVNeo procedure to theadvanced techniques of transforming abicuspid valve into a tricuspid valve.
Module II shiJs to hands-on Dry Lab
training by reconstrucDng a new aorDcvalve into a silicone model. This moduleoﬀers the opportunity to learn proper
measuring and sizing techniques and thestandardized approach to suturing thenew leaﬂets into the naDve annulus.
Module III includes in operaDng room
experience to see your Course Director
reconstruct the aorDc valve using theenDre AVNeo procedure.
Module IV is an opportunity for a
cerDﬁed AVNeo Proctor to visit yourfacility and support your ﬁrst AVNeo
cases.
We look forward to supporDng all yourtraining needs!

Comprehensive
AVNeo®
Training Program

Upcoming 2022 2-Day AVNeo Training Courses
Training Dates – Loca<on - Course Director
August 3 & 4 – PiAsburgh, PA, USA – Dr. Chu
August 16 & 17 – New Haven, CT, USA – Dr. Krane
September 20 & 21 – PiAsburgh, PA, USA – Dr. Chu
October TBD- New Haven, CT, USA – Dr. Krane
October TBD – Italy – Dr. Alber<niContact avneo_admin@jomdd.com to reserve your spot

Vol. 2 - July 2022

Missed the JOCS Live Talk? Don’t worry!

Last month the Journal ofCardiac Surgery selected
Yale’s newest manuscript
Aor$c valve neocuspidiza$on:
Frequently asked technicalques$ons to be discussed intheir weekend educaDonalsession.
Missed it? Don’t worry – you can sDll watch the replay via the link below!
hDps://youtu.be/rjdHGwLosps

What’s New in Research – 2022 AATS Recap
We enjoyed seeing everyone in Boston at AATS this year!
Dr. Anatol Prizing, German Heart Center – Munich, presented Mid-term
Results a.er Aor1c Valve Neocuspidiza1on during the Adult Cardiac Poster
presentaDons. Their results included 162 paDents with a mean age of 52.6years. They found peak and mean pressure gradients at discharge were
15.5mmHg/8.4mmHg and remained stable aPer four years. The 30-day
mortality rate was 0.6%, with overall survival rates of 98.8%, 97.8%, and97.8% at 1-year, 2-year, and 4-years. The overall mean freedom fromreoperaDon was 93.2%, with overall freedom from reoperaDon of 96.9%,96.1%, and 90.6% at 1-year, 2-year, and 4 years.
During the Cardiac Surgery Video Masterclass: AorDc session, Dr. Shinya Unai
from Cleveland Clinic, presented The Ozaki Procedure featuring a case reporton a 57 y/o male without signiﬁcant PMH aPer presenDng with heart failure
symptoms and AI with a bicuspid valve. Dr. Unai performed the procedure
uDlizing three size 35mm leaﬂets. Cross clamp Dme was 127 minutes. The
postop TEE showed trace AI with peak/mean gradients at 8/5 mmHg. The
paDent was discharged home aPer a 5-day uneven^ul hospital stay. Dr. Unai
reported that Cleveland had performed the procedure on 47 adult paDents
with a mean age of 51 between 2016 and 2/2021 (30 cases since thebeginning of 2021 = ~ 80 paDents). They have had no major complicaDons
post-op with the mean gradient of 7mmHg predischarge without an increasein gradient during follow-up.
Dr. Lynn Sleeper, ScienDﬁc Director of Cardiology Clinical Research Program atBoston Children’s Hospital, provided an update on the AVNeo/BCH Registryduring the AVNeo User Group MeeDng. There are currently>400 (195 peds;222 adults) paDents in the database, with 12 global sites and four addiDonalsites ready to enroll. Registry parDcipants receive registry enrollment andbenchmarking reports and opportuniDes for collaboraDon on mulDcenterresult manuscripts.
For more informaDon about joining the registry, please
complete this AVNeo Registry Inquiry form.